For millions of Americans trying to lose weight, GLP-1 medications have completely changed the conversation.
Instead of relying solely on restrictive dieting, calorie counting and endless cycles of losing and regaining weight, medications that influence appetite and satiety are giving qualifying patients another option to discuss with their healthcare providers.
Two names in particular have become major players in medically supervised weight management: semaglutide and tirzepatide.
But while demand has skyrocketed, so have questions.
What is the difference between them? How much weight can people actually lose? How much does treatment cost? And is there a legitimate way to access physician-guided treatment without battling insurance companies or paying premium brand-name prices?
Here’s what consumers should know.
Why GLP-1 Medications Have Become So Popular
GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone involved in appetite, digestion and blood-sugar regulation.
Medications that activate GLP-1 receptors can help reduce appetite and increase feelings of fullness, making it easier for some patients to consume fewer calories.
That is one reason people often describe experiencing less persistent hunger or less “food noise” while undergoing GLP-1 therapy.
These medications aren’t magic shots, however. They are prescription medications, and the best results generally occur when treatment is combined with nutritional improvements, physical activity and ongoing medical supervision.
Semaglutide: The GLP-1 That Helped Change Weight Loss
Semaglutide is a GLP-1 receptor agonist and became one of the medications responsible for bringing medical weight management into the mainstream.
In the landmark STEP 1 clinical trial involving adults with overweight or obesity, participants receiving semaglutide along with lifestyle intervention experienced an average body-weight reduction of approximately 14.9% over 68 weeks, compared with about 2.4% for participants receiving placebo. Individual results varied considerably.
That level of weight reduction helped demonstrate that medically supervised obesity treatment could produce results beyond what many people historically associated with traditional diet programs.
Why patients may consider semaglutide
Semaglutide may help qualifying patients:
- Reduce appetite
- Feel satisfied with smaller portions
- Reduce persistent thoughts about food
- Better adhere to a reduced-calorie eating plan
- Achieve meaningful long-term weight reduction when combined with lifestyle changes
For many patients, semaglutide represents a well-established starting point when discussing GLP-1 weight-management therapy with a healthcare provider.
Tirzepatide: The Dual-Action Alternative
Tirzepatide works somewhat differently.
Rather than targeting GLP-1 receptors alone, tirzepatide activates both GLP-1 and GIP receptors.
That dual mechanism has made tirzepatide particularly interesting within medical weight management.
In the SURMOUNT-1 clinical trial, average weight reduction at 72 weeks ranged from approximately 15% at the 5 mg dose to 20.9% at the 15 mg dose, compared with approximately 3.1% with placebo.
More than half of participants receiving the highest studied dose lost at least 20% of their starting body weight.
Again, those are clinical-trial averages — not a promise of what any individual patient will experience.
Why patients may consider tirzepatide
Depending on medical history and provider recommendations, tirzepatide may be considered by patients looking for:
- Significant appetite control
- Reduced cravings
- Support for substantial weight reduction
- A medication affecting both GLP-1 and GIP pathways
- Physician-guided long-term weight management
Semaglutide vs. Tirzepatide: What’s the Difference?
While both medications can be used within medically supervised weight-management programs, they aren’t exactly the same.
Semaglutide
Acts primarily on the GLP-1 receptor and has an extensive body of clinical evidence supporting its role in weight management.
Tirzepatide
Acts on both GLP-1 and GIP receptors and produced greater average weight reduction at higher doses in its major obesity clinical trial.
That doesn’t automatically mean tirzepatide is the better medication for every patient.
Health history, medications, previous treatments, side effects, weight-loss goals and other medical factors can all affect which option a licensed healthcare provider recommends.
The Problem: Access Can Get Complicated
The science behind GLP-1 therapy is impressive.
Access is often another story.
Depending on the medication and insurance plan, consumers can encounter:
- High out-of-pocket costs
- Insurance exclusions
- Prior authorization requirements
- Difficulty scheduling appointments
- Multiple separate medical and pharmacy charges
- Confusing membership fees
- Changing prices as dosages increase
That has helped fuel the growth of physician-guided telehealth weight-management programs.
One option getting attention is Thinnex.
Thinnex: A Simpler Approach to Physician-Guided Weight Loss
Thinnex offers qualifying patients access to medically supervised weight-management programs through telehealth.
Rather than requiring repeated trips to a traditional weight-loss clinic, patients begin by completing a medical intake that is reviewed by a licensed medical provider.
When clinically appropriate, the provider can prescribe a patient-specific compounded medication.
Thinnex currently offers programs involving compounded semaglutide and compounded tirzepatide, with medication delivered directly to the patient.
The model is designed around something consumers increasingly want from healthcare:
Make it straightforward.
What Makes Thinnex Interesting
Physician-Guided Care
GLP-1 treatment shouldn’t begin with clicking a “buy now” button and hoping for the best.
Patients complete a medical history and eligibility process, and prescribing decisions are made by licensed medical providers.
Semaglutide and Tirzepatide Options
Thinnex provides access to compounded semaglutide and tirzepatide when prescribed and medically appropriate, allowing providers and patients to determine which treatment path makes sense.
Straightforward Pricing
One of the more frustrating aspects of many telehealth programs is discovering that the advertised price doesn’t include everything.
Thinnex promotes flat-rate programs that include the medication, telehealth medical review and shipping rather than layering separate membership and fulfillment charges onto the advertised price.
At the time of publication, programs advertised through Thinnex started as low as $149 per month for longer-term compounded semaglutide plans, with compounded tirzepatide programs starting at a higher monthly price depending on plan length.
Pricing and availability can change, so consumers should verify current pricing directly with Thinnex.
No Insurance Required
Thinnex’s programs don’t require insurance approval.
For people whose health plans exclude obesity medications or impose extensive authorization requirements, that alone may make the process significantly easier.
Medication Delivered Directly to You
Prescribed treatment is shipped directly to the patient, eliminating the routine pharmacy run and creating a primarily at-home treatment experience.
What About Compounded GLP-1 Medications?
This is an important distinction consumers should understand.
Compounded medications are not FDA-approved drugs.
The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed in the same way it reviews FDA-approved medications.
Compounding nevertheless has an established role in American healthcare and may be appropriate for a patient when a licensed healthcare provider determines that a compounded medication is medically appropriate and applicable federal and state requirements are met.
Consumers should discuss the benefits, risks and sourcing of any compounded medication directly with their healthcare provider.
Thinnex states that its patients undergo a telehealth medical intake and that prescriptions are issued by licensed providers when medically appropriate.
What Are the Common Side Effects of GLP-1 Therapy?
Like virtually every prescription medication, GLP-1 treatments can cause side effects.
Common gastrointestinal effects can include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
- Reduced appetite
More serious complications can occur, which is one reason medical screening and ongoing provider involvement are important.
Certain people may not be appropriate candidates for GLP-1 therapy based on their medical history, other medications or specific health conditions.
A licensed healthcare provider should make that determination — not a social media influencer, online quiz or before-and-after photo.
Do You Still Need to Eat Well and Exercise?
Yes.
GLP-1 therapy can make eating less considerably easier for some people, but it doesn’t eliminate the importance of nutrition or physical activity.
In fact, because appetite can decline substantially, the quality of what you eat may become even more important.
Patients should work toward adequate protein, nutrient-dense foods, fruits and vegetables, fiber and appropriate hydration while maintaining physical activity appropriate for their health and fitness level.
Resistance training can also be particularly valuable during significant weight loss because weight reduction can include both fat and lean tissue.
The goal shouldn’t simply be making the number on the scale smaller.
It should be improving health and body composition in a sustainable way.
So, Which GLP-1 Option Is Best?
There isn’t one medication that is automatically best for everyone.
Semaglutide has extensive clinical evidence and remains one of the most recognized GLP-1 therapies in weight management.
Tirzepatide’s dual GLP-1/GIP mechanism has produced particularly impressive average weight-loss results in clinical research.
The right choice depends on the patient.
And that’s ultimately why medically supervised programs matter.
Instead of selecting a medication because it’s trending on TikTok or because a celebrity mentioned it, patients should work with a qualified medical provider who can review their history, goals, medications and potential risks.
Our Take on Thinnex
For consumers who are interested in exploring GLP-1 weight management but don’t want to navigate the traditional combination of doctor’s appointments, insurance approvals, pharmacy visits and unpredictable fees, Thinnex offers an interesting alternative worth considering.
Its combination of telehealth access, physician-guided treatment, direct-to-door fulfillment and relatively straightforward pricing removes several of the barriers that have made medically supervised weight loss frustrating for consumers.
It won’t be appropriate for everyone, and treatment still requires medical approval.
But for qualifying patients looking for a more convenient way to explore semaglutide or tirzepatide treatment with a licensed provider, Thinnex provides a compelling place to start.
Ready to see if you qualify?
Learn more about Thinnex and begin the confidential medical intake process at Thinnex.com.
Important Medical Information
This article is for informational purposes only and does not constitute medical advice. Prescription medications should only be used under the supervision of a licensed healthcare professional.
Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness or quality before they are marketed. A healthcare provider should determine whether a compounded medication is appropriate based on an individual’s medical needs.
Individual weight-loss results vary. Clinical-trial results discussed in this article involved specific study populations, medication formulations, dosages and lifestyle interventions and should not be interpreted as expected results for Thinnex patients or users of compounded medications.
